Tari A King MD

PubMed

• Assessing racial disparities in disease outcomes of patients with high-risk, triple-negative breast cancer and residual disease after neoadjuvant therapy: a post-hoc a...
  Kate Lloyd, Lisa A Newman, Charity Glass, Esther R Ogayo, Erica L Mayer
  Breast Cancer Research and Treatment. 2025-08-04
• Breast imaging recommendations for young females (age < 40 years) with ≥ 20% lifetime breast cancer risk: practice patterns at a specialized clinic.
  Alexandra Wehbe, Fisher Katlin, Eshita Sharma, Marybeth Hans, Mary Knust Graichen
  Breast Cancer Research and Treatment. 2025-08-01
• 1 citations
  Long-Term Locoregional Outcomes in a Contemporary Cohort of Young Women With Breast Cancer.
  Laura S Dominici, Yue Zheng, Tari A King, Julia Wong, Kathryn J Ruddy
  JAMA Surgery. 2025-07-23

Journal Articles

• Molecular Mechanisms Linking High Body Mass Index to Breast Cancer Etiology in Post-Menopausal Breast Tumor and Tumor-Adjacent Tissues  
  Adam M Brufsky, Tari A King, Susan B Brown, Breast Cancer Research and Treatment
• Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma in Situ Following a Core Biopsy Diagnosis of Non-Classic Lobular Carcinoma in Situ  
  Kevin S Hughes, Suzanne B Coopey, Faina Nakhlis, Catherine S Giess, Susan C Lester, Tari A King, Annals of Surgical Oncology
• Correction to: Margins in Breast-Conserving Surgery After Neoadjuvant Therapy  
  Tari King, Mehra Golshan, Annals of Surgical Oncology
• Implementation of a Venous Thromboembolism Prophylaxis Protocol Using the Caprini Risk Assessment Model in Patients Undergoing Mastectomy  
  Faina Nakhlis, Stephanie Caterson, Yoon Chun, Tari A King, Mehra Golshan, Laura S Dominici, Nathan Connell, Margaret Duggan, Matthew Carty, Annals of Surgical Oncology
• Incorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging System  
  Kelly K Hunt, Tari A King, Anna Weiss, The Surgical Clinics of North America
• Chronic Pain After Breast Surgery: A Prospective, Observational Study  
  Kristin L Schreiber, Tara L Spivey, Nantthasorn Zinboonyahgoon, Tari A King, Laura Dominici, Mehra Golshan, Annals of Surgical Oncology
• Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series  
  Laura Dominici, Tari A King, Suniti Nimbkar, Jennifer K Plichta, Margaret Duggan, Katharine Carter, Faina Nakhlis, Mehra Golshan, Esther Rhei, Jennifer Bellon, Rinaa P..., Annals of Surgical Oncology
• The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy  
  Faina Nakhlis, Tari A King, Annals of Surgical Oncology
• Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma in Situ  
  Wong S, King T, Boileau JF, Barry B, Golshan M, Ann Surg Oncol, 1/28/2017
• Bi-allelic alterations in DNA repair genes underpin Homologous recombination DNA repair defects in breast cancer  
  Mutter RW, Riaz N, Ng CK, Delsite R, Piscuoglio S, Edelweiss M, Martelotto LG, Sakr RA, King TA, Giri DD, Drobnjak M, Brogi E, Bindra R, Bernheim G, Lim RS, Blecua P, ..., J Pathol, 1/15/2017
• Evaluation of Local and Distant Recurrence Patterns in Patients with Triple-Negative Breast Cancer According to Age  
  Radosa JC, Eaton A, Stempel M, Khander A, Liedtke C, Solomayer EF, Karsten M, Pilewskie M, Morrow M, King TA, Ann Surg Oncol, 1/1/2017
• Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples  
  Martelotto LG, Baslan T, Kendall J, Geyer FC, Burke KA, Spraggon L, Piscuoglio S, Chadalavada K, Nanjangud G, Ng CK, Moody P, D'Italia S, Rodgers L, Cox H, da Cruz Pau..., Nat Med, 1/1/2017
• HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures  
  Davies H, Glodzik D, Morganella S, Yates LR, Staaf J, Zou X, Ramakrishna M, Martin S, Boyault S, Sieuwerts AM, Simpson PT, King TA, Raine K, Eyfjord JE, Kong G, Borg A..., 1/1/2017
• Landscape of somatic mutations in 560 breast cancer whole-genome sequences  
  Nik-Zaina S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S..., Nature, 1/1/2016
• Biomarkers that predict sensitivity to heat shock protein 90 inhibitors  
  Jhaveri K, Chandarlapaty S, Iyengar N, Morris PG, Corben AD, Patil S, Akram M, Towers R, Sakr RA, King TA, Norton L, Rosen N, Hudis C, Modi S, Clin Breast Cancer, 1/1/2016
• Skin flap necrosis after mastectomy with reconstruction: A prospective study  
  Matsen CB, Mehrara B, Eaton A, Capko D, Berg A, Stempel M, Van Zee KJ, Pusic A, King TA, Cody HS, Pilewskie M, Cordeiro P, Sclafani L, Plitas G, Gemignani ML, Disa J, ..., Ann Surg Oncol, 1/1/2016
• Oncotype DX in bilateral synchronous primary invasive breast cancer  
  Karsten M, Stempel M, Radosa J, Patil S, King TA, Ann Surg Oncol, 1/1/2016
• Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in situ in patients with lobular neoplasia on core biopsy: results from a prospective mult...  
  Nakhlis F, Gilmore L, Gelman R, Bedrosian I, Ludwig K, Hwang ES, Willey S, Hudis C, Iglehart JD, Lawler E, Ryabin NY, Golshan M, Schnitt SJ, King TA, Ann Surg Oncol, 1/1/2016
• Factors affecting completion of adjuvant chemotherapy in early stage breast cancer  
  Reyes S, Kezhen F, Franco R, King TA, Bickell N, Ann Surg Oncol, 1/1/2016
• The Genomic Landscape of Male Breast Cancers  
  Piscuoglio S, Ng C, Murray M, Guerini-Rocco E, Martelotto L, Geyer F, Bidard FC, Berman S, Fusco N, Sakr R, Eberle C, De Mattos-Arruda L, Macedo G, Baslan T, Hicks J, ..., Clin Cancer Res, 1/1/2016
• Is Sentinel Lymph Node Biopsy Indicated at Completion Mastectomy for Ductal Carcinoma In Situ?  
  Pilewskie M, Karsten M, Radosa J, Eaton A, King TA, Ann Surg Oncol, 1/1/2016
• Selection of Optimal Adjuvant Chemotherapy Regimens for Early Breast Cancer and Adjuvant Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast ...  
  Denduluri N, Somerfield MR, Eisen A, Holloway JN, Hurria A, King TA, Lyman GH, Partridge AH, Telli ML, Trudeau ME, Wolff AC, J Clin Oncol, 1/1/2016
• Timeliness in Breast Cancer Treatment - The Sooner, the Better  
  Waks AG, King TA, Winer EP, JAMA Oncol, 1/1/2016
• Clonal relationships between lobular carcinoma in situ and other breast malignancies  
  Begg CB, Ostrovnaya I, Scarpa Carniello JV, Sakr RA, Giri D, Towers R, Schizas M, De Brot M, Andrade VP, Mauguen A, Seshan VE, King TA, Breast Cancer Res, 1/1/2016
• How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study  
  Mamtani A, Barrio AV, King TA, Van Zee KJ, Plitas G, Pilewskie M, El-Tamer M, Gemignani ML, Heerdt AS, Sclafani LM, Sacchini V, Cody HS 3rd, Patil S, Morrow M, Ann Surg Oncol, 1/1/2016
• Join now to see all

Books/Book Chapters

• Diseases of the Breast 
  Chapter: Lobular Carcinoma In Situ: Biology and Management 
  Page 324 - 336King TA, Reis-Filho JSEditors: Harris JR, Lippman ME, Morrow M, Osborne K.Lippincott, Williams, and Wilkins, Philadelphia, PAEdition 5th,2014
• Current Surgical Therapy 
  Chapter: Cellular, Biochemical and Molecular Targets in Breast Cancer 
  Page 520 - 524King TA, Morrow MEditors: Cameron JL, Cameron AM.Mosby, New York, NYEdition 10th,2010
• Advanced Therapy of Breast Disease 
  Chapter: Management of High Risk Breast Lesions 
  Andrade VP, King TAEditors: Esteva F, Skoracki R and Gildy B.People's Medical Publishing House, CTEdition 3rd,2010
• Greenfield's Surgery, Scientific Principles & Practice 
  Chapter: Breast Disease 
  King TAEditors: Mulholland MW, Lillemoe, KD, Doherty GM, Maier RV, Upchurch GR.Lippincott, Williams and Wilkins, Philadelphia, PAEdition 5th,2010
• Principles & Practice of Cancer Rehabilitation 
  Chapter: Principles of Breast Surgery 
  McLaughlin SA, King TAEditors: Stubblefield, O'Dell, Custodio, Fitzpatrick.Demos Medical Publishing, New York, NY2009
• Diseases of the Breast 
  Chapter: Surgery for the Primary in Patients with Distant Metastases 
  King TAEditors: Harris JR, Lippman ME, Morrow M, Osborne CK.Lippincott, Williams and Wilkins, Philadelphia, PA2009
• Atlas of Procedures in Breast Cancer Surgery 
  Chapter: Central Lumpectomy with Resection of the Nipple-Areolar Complex 
  King TA, Borgen PIEditors: King TA, Borgen PI.Martin Dunitz, Ltd., London, UK2005
• Atlas of Procedures in Breast Cancer Surgery 
  Chapter: Nipple-Sparing Mastectomy 
  King TA, Borgen PIEditors: King TA, Borgen PI.Martin Dunitz, Ltd., London, UK2005
• Atlas of Procedures in Breast Cancer Surgery 
  Chapter: Male Breast Cancer. 
  King TA, Borgen PIEditors: King TA, Borgen PI.Martin Dunitz, Ltd., London, UK2005
• Atlas of Procedures in Breast Cancer Surgery 
  Chapter: Wide Local Excision with Intraoperative Radiation Therapy 
  King TA, Borgen PIEditors: King TA, Borgen PI.Martin Dunitz, Ltd., London, UK2005
• The Conservative Treatment of the Early Breast Cancer 
  Chapter: Breast Conservation: The Role of Lumpectomy in the Surgical Treatment of Early Invasive Breast Cancer 
  King TA, Borgen PIEditors: Peltecu GC.BIC ALL, Bucharest, Romania2003
• Join now to see all

Abstracts/Posters

• Management of the Axilla in Clinical T1-2N0 Patients Undergoing Mastectomy - What Can We Learn from AMAROS?
  Moossdorff M, Nakhlis F, Hu J, Barry W, Losk K, Haskett C, Smidt ML, King TA, Society of Surgical Oncology annual meeting, Seattle, WA, 1/1/2017
• Implementation of Surgeon-Initiated Oncotype DX Ordering Among Breast Cancer Patients to Reduce Chemotherapy Wait Times
  Losk K, Freedman RA, Lin NU, Golshan M, Lester S, Pochebit S, Natsuhara K, Camuso K, King TA, Bunnell CA, American Society of Clinical Oncology Quality Care Symposium, Orlando, FL, 1/1/2017
• Patterns of axillary evaluation in older patients (pts) with breast cancer and impact on adjuvant therapy
  Dominici LS, Sineshaw H, Jemal A, Lin A, King TA, Freedman RA, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2016
• Multifocality and bilaterality of lobular carcinoma in situ in women with synchronous malignancies
  Scarpa Carniello JV, Giri D, De Brot M, Towers R, Andrade VP, King TA, American Society of Clinical Pathology Annual Meeting, Las Vegas, NV, 1/1/2016
• Factors associated with the decision to pursue elective surgery among women enrolled in TBCRC013: A prospective registry of surgery in patients presenting with stage I...
  Plichta JK, Reyes S, Frank E, Gonen M, Voci A, Boafo C, Hwang S, Rugo H, Alvarado M, Liu M, Boughey J, Jacobs L, Krontiras H, McGuire K, Storniolo A, Nanda R, Golshan ..., American Society of Breast Surgeons Annual Meeting, Dallas, TX, 1/1/2016
• Morbidity of Primary Local Therapy for Locally Advanced Metastatic Breast Cancer: An Analysis of the Surveillance, Epidemiology and End Results (SEER) - Medicare Registry
  Fairweather M, Jiang W, Keating N, Freedman R, King TA, Nakhlis F, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2015
• A Functional Assay for Homologous Recombination (HR) DNA Repair and Whole Exome Sequencing Reveal that HR-Defective Sporadic Breast Cancers are Enriched for Genetic Al...
  Riaz N, Mutter RW, Ng CKY, Delsite R, Piscuoglio S, King TA, Martelotto L, Sakr R, Brogi E, Edelweiss M, Lim R, Higginson D, Weigelt B, Lee W, Reis-Filho JS, Powell SN, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2015
• Treatment Outcomes in Patients with Invasive Breast Cancer Treated with Neoadjuvant Systemic Therapy and Breast MR Imaging: Results of a Secondary Analysis of TBCRC 017
  De Los Santos J, Hyslop T, Alvarado M, Forero A, Golshan M, Hieken T, Horton J, Hudis C, King T, McGuire K, Meric-Bernstam F, Nanda R, Zagar T, Hwang S, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2015
• Lobular Carcinoma in Situ Displays Intra-Lesion Genetic Heterogeneity and its Progression to Invasive Disease Involves Clonal Selection and Variations in Mutational Pr...
  Reis-Filho JS, Schizas M, Piscuoglio S, Sakr RA, Ng CKY, Lim RS, Carniello JVS, Towers R, Martelotto L, Giri DD, de Andrade VP, Viale A, Solit DB, Weigelt B, King TA, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2015
• Germline CDH1 mutations in lobular carcinoma in situ
  Reyes S, Sakr R, Schizas M, Ng CKY, Towers R, Park AY, Weigelt B, Reis-Filho JS, King TA, San Antonio Breast Cancer Symposium, San Antonio, San Antonio, TX, 1/1/2015
• Whole exome sequencing reveals heterogeneity within lobular carcinoma in situ (LCIS) and clonal selection in the progression to clinically malignant lesions
  Schizas M, Sakr RA, Weigelt B, Ng CKY, Carniello JVS , Giri D, Piscuoglio S, Martelotto LG, Towers R, Andrade VP, Lim R, Solit DB, Reis-Filho JS, King TA, AACR Annual Meeting, Philadelphia, PA, 1/1/2015
• Intra-tumor heterogeneity and clonal changes in the progression of DCIS to invasiveness: Combined tumor bulk and single cell analysis
  Sakr R, Martelotto LG, Baslan T, Ng CKY, Kendall J, Rodgers L, Cox H, Riggs M, D’Italia S, Stepansky A, Olvera N, King TA, Weigelt B, Reis-Filho JS, Hicks J, AACR Annual Meeting, Philadelphia, PA, 1/1/2015
• Metaplastic breast cancer is resistant to standard breast cancer treatment modalities
  Mautner S, Giri D, Stempel M, Patil S, Eaton A, Van Zee KJ, King TA, Morrow M, Plitas G, Society of Surgical Oncology, Houston, TX, 1/1/2015
• The extent of lobular carcinoma in situ (LCIS) at surgical excision predicts for the development of subsequent breast cancer
  Gooch JC, Guerini-Rocco E, Patil S, Koslow S, Debrot M, Park A, Boafo C, Reis-Filho J, King TA, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2014
• Lobular Carcinoma in Situ: What happens after chemoprevention?
  Koslow S, Park A, Muhsen S, Sakr R, King TA, Society of Surgical Oncology, Phoenix, AZ, 1/1/2014
• Alternate mechanisms of PI3K pathway activation among subtypes of ductal carcinoma in situ suggest distinct pathways for progression to invasive disease
  Sakr R, Chandarlapaty S, Barbashina V, Andrade VP, Morrogh M, Arroyo CD, Olvera N, Paik W, Heguy A, Patil S, Rosen N, Morrow M, King TA, AACR 100th Annual Meeting, Washington, DC, 1/17/2010
• PI3K mutations are more common in low grade DCIS
  Sakr R, Chandarlapaty S, Andrade V, Muhsen S, Paik W, Morrow M, Rosen N, King TA, San Antonio Breast Cancer Symposium; 2010 Annual Meeting, San Antonio, TX, 1/8/2010
• Join now to see all

Lectures

• RANK-C Attenuates Aggressive Properties of ER-Negative Breast Cancer by Inhibiting NF-κB Activation and EGFR Signaling 
  New York, NY - 10/29/2014
• Changing the Future of Breast Cancer 
  Palm Beach, FL - 1/1/2017
• Lobular Carcinoma in Situ: Risk Factor or Precursor 
  Beth Israel Deaconess Medical Center, Boston, MA - 1/1/2017
• Surgical Considerations in Patients Receiving Neoadjuvant Chemotherapy 
  Mount Auburn Hospital, Cambridge, MA - 1/1/2017
• Surgical Updates from SABC 
  Omaha, NE - 1/1/2017
• Dealing with Harassment in the Workplace 
  Chicago, IL - 1/1/2017
• In situ Carcinoma and Borderline Controversies 
  Las Vegas, NV - 1/1/2017
• Genomic Assays and Patient Outcomes: Real World Applications 
  Las Vegas, NV - 1/1/2017
• Surgical Management of Breast Cancer 
  Guangzhou, China - 1/1/2017
• Contralateral Mastectomy: Hype or hope 
  Medical University of Vienna, Vienna, Austria - 1/1/2017
• Age and Molecular Subtypes: Impact on surgical decisions 
  Vienna, Austria - 1/1/2017
• Controversies in Local Therapy in the Patient Receiving Neoadjuvant Chemotherapy 
  1/1/2016
• Pathology and Decision Making in Breast Cancer: The Surgeon's Perspective 
  Boston, MA - 1/1/2016
• The Molecular Biology of LCIS 
  Boston, MA - 1/1/2016
• Surgical Considerations in Inflammatory Breast Cancer 
  Boston, MA - 1/1/2016
• Update on Breast Surgery: High Risk Patients / Update on Breast and Gynecologic Cancers 
  Dana-Farber Cancer Institute, Boston, MA - 1/1/2016
• Lobular Carcinoma in Situ 
  Dana-Farber Cancer Institute, Boston, MA - 1/1/2016
• DF/HCC Clinical Trials Update Part 2: Local Therapy and ER plus Trials 
  Dana-Farber Cancer Institute, Boston, MA - 1/1/2016
• Is There a Role for Surgery in Stage IV Disease? 
  Dana-Farber Cancer Institute, Boston, MA - 1/1/2016
• Management of Advanced Breast Cancer 
  Dana-Farber Cancer Institute, Boston, MA - 1/1/2016
• Margins - Challenges and Opportunities 
  Beth Israel Deaconess Medical Center, Boston, MA - 1/1/2016
• Local Therapy/Regional Therapy / Tumor Board 
  Dana-Farber Cancer Institute, Boston, MA - 1/1/2016
• VTE prophylaxis discussion 
  Dana-Farber Cancer Institute, Boston, MA - 1/1/2016
• Tissue Banking and Clinical Translation of MBC Research 
  Dallas, TX - 1/1/2016
• Incorporating Breast Density Into Risk Assessment and Patient Counseling 
  Dallas, TX - 1/1/2016
• Join now to see all